ArticleCurrent cancer drug targets2026
YPEL1 Inhibits Development of Gemcitabine Resistance in NK / T Cell Lymphomas.
Miao Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleCurrent cancer drug targets2026
Miao Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.